This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Lincoff AM, Wolski K, Nicholls SJ, Nissen SE.Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA: the Journal of the American Medical Association 298: 1180-1188, No. 10, 12 Sep 2007
Singh S, Loke YK, Furberg CD.Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA: the Journal of the American Medical Association 298: 1189-1195, No. 10, 12 Sep 2007
Takeda Pharmaceuticals North America Inc.Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association. Media Release: 11 Sep 2007. Available from: URL: http://www.tpna.com
GlaxoSmithKline.GlaxoSmithKline Responds to JAMA Articles. Media Release: 11 Sep 2007. Available from: URL: http://www.gsk.com
Solomon DH, Winkelmayer WC.Cardiovascular risk and the thiazolidinediones: deja vu all over again? JAMA: the Journal of the American Medical Association 298: 1216-1218, No. 10, 12 Sep 2007
About this article
Cite this article
Pioglitazone, rosiglitazone face up to MI, HF risk analyses. React. Wkly. 1170, 5 (2007). https://doi.org/10.2165/00128415-200711700-00010
- Heart Failure
- Myocardial Infarction